COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 191 filers reported holding COHERUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,762,734 | -11.0% | 2,342,977 | +1.6% | 0.28% | -4.4% |
| Q2 2023 | $9,846,797 | -36.1% | 2,306,041 | +2.3% | 0.30% | -37.9% |
| Q1 2023 | $15,418,060 | -6.7% | 2,254,102 | +8.0% | 0.48% | -8.4% |
| Q4 2022 | $16,525,665 | -19.7% | 2,086,574 | -2.6% | 0.52% | -25.1% |
| Q3 2022 | $20,579,000 | +22.4% | 2,141,380 | -7.8% | 0.70% | +38.6% |
| Q2 2022 | $16,812,000 | -40.6% | 2,322,168 | +5.9% | 0.50% | -29.8% |
| Q1 2022 | $28,306,000 | -15.0% | 2,192,602 | +5.1% | 0.72% | -8.5% |
| Q4 2021 | $33,312,000 | -3.8% | 2,087,187 | -3.2% | 0.78% | -3.9% |
| Q3 2021 | $34,634,000 | +25.8% | 2,155,221 | +8.3% | 0.81% | +29.0% |
| Q2 2021 | $27,528,000 | -10.3% | 1,990,443 | -5.3% | 0.63% | -7.8% |
| Q1 2021 | $30,706,000 | -0.9% | 2,101,687 | +17.9% | 0.68% | -6.9% |
| Q4 2020 | $30,990,000 | +80.3% | 1,783,080 | +90.2% | 0.73% | +47.4% |
| Q3 2020 | $17,190,000 | +56.5% | 937,274 | +52.4% | 0.50% | +49.1% |
| Q2 2020 | $10,984,000 | – | 615,032 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |